Central Nervous System Diseases - drug therapy.

Animal and translational models for CNS drug discovery by: (Electronic resources)

Handbook of neuroemergency clinical trials by: (Electronic resources)

Handbook of neuroemergency clinical trials by: (Electronic resources)

The third histamine receptor = selective ligands as potential therapeutic agents in CNS disorders / by: (Electronic resources)

Nanotechnology methods for neurological diseases and brain tumors : = drug delivery across the blood--brain barrier / by: (Electronic resources)

Blood-brain barrier in drug discovery = optimizing brain exposure of CNS drugs and minimizing brain side effects for peripheral drugs / by: (Electronic resources)

Neuropsychopharmacology and therapeutics by: (Electronic resources)

Disease Models, Animal.

Blood-Brain Barrier- metabolism.

Drug Discovery- methods.

Central Nervous System Diseases- drug therapy.

Neuropharmacology- Research.

Clinical Trials- methods.

Syst�eme nerveux- Maladies

Neuropharmacologie

�Etudes cliniques

Neuropsychopharmacology.

Blood-brain barrier- Effect of drugs on.

Nanotechnology.

Blood-brain barrier- Metabolism.

Central Nervous System Agents- pharmacokinetics.

Drug-Related Side Effects and Adverse Reactions- prevention & control.

Neuropharmacology

Neuroprotective Agents- therapeutic use.

Receptors, Histamine H3- metabolism.

Drug development.

Blood-Brain Barrier- drug effects.

Nervous system- Diseases

Histamine H3 Antagonists- therapeutic use.

Nanomedicine- methods.

Mental Disorders- drug therapy.

Animal models in research.

Clinical trials

Histamine- Receptors.

Antihistamines.

Therapeutics.

Central Nervous System Agents- therapeutic use.

Central Nervous System- drug effects.

Central nervous system- Diseases

Drug Discovery.

Neuropharmacology- methods.

Emergency Medicine- methods.

Drug Delivery Systems.